Discussion : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis [1]
According to the eighth European Workshop of Periodontology (EFP), evaluation of the effectiveness of different peri-implantitis therapies should be based on a composite outcome of disease resolution, including resolutions of mucosal inflammation, reductions in probing pocket depths, and no further bone loss [3].
The current retrospective clinical investigation evaluated treatment outcomes following combined surgical therapy for peri-implantitis at formerly grafted and non-grafted implant sites. A composite outcome of disease resolution as the absence of BOP and PD ≥ 6 mm was considered. Accordingly, peri-implantitis resolution was achieved in 33% of the treated implants, corresponding to 28% of the patients. Although no significant difference regarding grafting of the implant site was detected at the patient level (grafted sites 4/10 (40%), non-grafted sites 7/29 (24.1%), p = 0.579), implant-level analysis pointed to a higher disease resolution at the grafted implant sites (9/16 (56%) at grafted sites, 10/41 (25%) at non-grafted sites, p = 0.048).
The disease resolution noted in the present analysis is in line with the data reported in previous clinical studies. In particular, the treatment success (defined as absence of BOP) following combined surgical therapy was obtained in 60% (9/15) of the patients in the 7 years of clinical investigation [16]. Additionally, according to the results of the studies reporting on the composite treatment outcomes following surgical regenerative peri-implantitis therapy, treatment success was achieved in 35% (9/26) (treatment success defined as PD < 5 mm, absence of BOP/suppuration, no further bone loss) [17] to 51.1% (23/45) of the implants (treatment success defined as evidence of ≥ 25% bone fill, PD < 5 mm, BOP score ≤ 1) at 5 and 7 years of follow-up, respectively [18]. However, in this context, it should be realized that these studies used different criteria to define treatment success; hence, clinical outcomes cannot be compared directly.
In the present study, mean BOP reduction ranged from 60.64 to 77.45% at the patient level and from 54.88 to 74.96% at the implant level, with no significant difference between the grafted and non-grafted implants sites. Slightly higher mean BOP reduction values, ranging from 75.5 to 90%, were indicated in the long-term (7 years) clinical investigations following regenerative surgical therapy of peri-implantitis [16, 17]. It is interesting to note that BOP reduction was found to be significantly influenced by the implant-surface characteristics [17]. This observation is in agreement with the data presented in a 3-year randomized controlled clinical trial, where superior treatment outcomes were noted for implants with non-modified surface implants compared to modified surfaces [11].
Serial posts:
- Abstract : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis
- Background : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis
- Methods : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis [1]
- Methods : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis [2]
- Methods : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis [3]
- Results : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis [1]
- Results : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis [2]
- Discussion : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis [1]
- Discussion : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis [2]
- Conclusions : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis
- References : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis [1]
- References : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis [2]
- References : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis [3]
- Funding : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis
- Author information : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis
- Ethics declarations : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis
- Rights and permissions : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis
- About this article : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis
- Table 1 Implant site characteristics : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis
- Table 2 Disease resolution between the non-grafted and grafted implant sites : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis
- Table 3 Reduction of mean BOP (%) : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis
- Table 4 Reduction of maximum PD (mm) : Clinical outcomes following surgical treatment of peri-implantitis at grafted and non-grafted implant sites: a retrospective analysis
- Fig. 1. Combined surgical therapy of peri-implantitis at respective defect sites: class I: intrabony component showing either a buccal dehiscency with a semicircular component (Ib) or a buccal dehiscency with a cicumferential component (Ic). Class II: supracrestal component. The red rectangles indicate the surface areas undergoing an implantoplasty, while the green areas indicate the defect areas undergoing augmentative therapy : Clinical outcomes following surgical treatment of peri-implant
- Fig. 2. Box plot depicting no significant differences of the baseline maximum PD values between the grafted and non-grafted patient groups (p = 0.353) : Clinical outcomes following surgical treatment of peri-implant
- Fig. 3. Dumbbell—dot plots illustrating (a) disease resolution and no resolution at non-grafted and grafted sites at the patient level analysis with no significant difference between the two groups (p = 0.579). Patents with improvement, deterioration, and no improvement following the treatment based on the max PD changes are depicted; (b) disease resolution and no resolution at the implants in non-grafted and grafted sites. Significantly higher disease resolution in the grafted implant group (p = 0.048) : Clinical outcomes following surgical treatment of peri-implant
- Fig. 4. Box plot presenting mean BOP reduction between the two patient groups (grafted and non-grafted) with no significant difference (p = 0.778) : Clinical outcomes following surgical treatment of peri-implant
- Fig. 5. Box plot illustrating maximum PD reduction between the grafted and non-grafted patient groups that did not reach a significant difference (p = 0.968) : Clinical outcomes following surgical treatment of peri-implant